Atlas Trials

Pyrotinib Maleate Tablets in Combination With Dalpiciclib Isethionate Tablets and Standard Endocrine Therapy

Clinical trial NCT07189884 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07189884
Sponsor
The First Affiliated Hospital of Xiamen University
Status
NOT_YET_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Locally Advanced Breast Cancer (LABC)
Start date
2025-09-23
Primary completion
2026-06-30
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.